Goldman Sachs’s Intercure INCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,262,726
Closed -$2.07M 6618
2025
Q3
$2.07M Buy
+1,262,726
New +$1.96M ﹤0.01% 4445
2022
Q1
Sell
-47,378
Closed -$307K 6719
2021
Q4
$307K Buy
47,378
+6,588
+16% +$47.3K ﹤0.01% 5658
2021
Q3
$283K Buy
+40,790
New +$293K ﹤0.01% 5532

Other funds holding INCR

Goldman Sachs's INCR Position: Q4 2025 in Review

Goldman Sachs sold out of Intercure (INCR) in Q4 2025, closing a stake of 1,262,726 shares — an estimated $2.07M sold.

Goldman Sachs first reported a position in INCR in Q3 2021 and held it in 3 quarters. The position peaked at $2.07M in Q3 2025. 19 funds tracked by Wall St. Rank hold INCR as of Q4 2025.

  • Goldman Sachs reported no remaining Intercure position as of Q4 2025 after selling out during the quarter.
  • Goldman Sachs sold 1,262,726 Intercure shares in Q4 2025, an estimated $2.07M.
  • Goldman Sachs first reported a position in Intercure in Q3 2021 and held it in 3 quarters.
  • Goldman Sachs's Intercure position peaked at $2.07M in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Intercure as of Q4 2025.

Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.